Cervical cancer screening: Barriers to access and potential solutions for Nigeria
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinical and Biomedical Research |
Texto Completo: | https://seer.ufrgs.br/index.php/hcpa/article/view/52764 |
Resumo: | In developed countries, giant strides have been made in reducing mortality due to cervical cancer. The success recorded has been largely attributed to effective screening programmes. In contrast, the burden and mortality due to this disease is rising in developing countries. Access to screening services remains a major challenge for the majority of the population at risk. This paper reviews the current demand-side barriers to cervical cancer screening inNigeriaand identifies potential solutions. Using academic databases and grey literature, a review was carried out to identify current screening modalities, barriers to access, and potential solutions. The current innovative method for control is early detection and treatment using “See and Treat” which involves visual inspection of the cervix with acetic acid (VIA) and cryotherapy. Lack of awareness, cost, and availability were identified as major barriers to access. Potential solutions feasible in the Nigerian context were categorized as financial and non-financial. The potential financial interventions include voucher schemes, conditional cash transfers, health equity, community loan funds, and prepayment mechanisms. Potential non-financial interventions that would be useful include raising awareness via health education and counseling, community participation, community based interventions, and pre-payment mechanisms. |
id |
UFRGS-20_2e8fb674c5bd5797a00ee622cd56b752 |
---|---|
oai_identifier_str |
oai:seer.ufrgs.br:article/52764 |
network_acronym_str |
UFRGS-20 |
network_name_str |
Clinical and Biomedical Research |
repository_id_str |
|
spelling |
Cervical cancer screening: Barriers to access and potential solutions for Nigeriacervical cancercancer screeningdemand -developing countriesaccessOncologyIn developed countries, giant strides have been made in reducing mortality due to cervical cancer. The success recorded has been largely attributed to effective screening programmes. In contrast, the burden and mortality due to this disease is rising in developing countries. Access to screening services remains a major challenge for the majority of the population at risk. This paper reviews the current demand-side barriers to cervical cancer screening inNigeriaand identifies potential solutions. Using academic databases and grey literature, a review was carried out to identify current screening modalities, barriers to access, and potential solutions. The current innovative method for control is early detection and treatment using “See and Treat” which involves visual inspection of the cervix with acetic acid (VIA) and cryotherapy. Lack of awareness, cost, and availability were identified as major barriers to access. Potential solutions feasible in the Nigerian context were categorized as financial and non-financial. The potential financial interventions include voucher schemes, conditional cash transfers, health equity, community loan funds, and prepayment mechanisms. Potential non-financial interventions that would be useful include raising awareness via health education and counseling, community participation, community based interventions, and pre-payment mechanisms.HCPA/FAMED/UFRGS2015-03-19info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliados por Paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/52764Clinical & Biomedical Research; Vol. 35 No. 1 (2015): Clinical and Biomedical ResearchClinical and Biomedical Research; v. 35 n. 1 (2015): Clinical and Biomedical Research2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSenghttps://seer.ufrgs.br/index.php/hcpa/article/view/52764/33574Akwaowo, Christie DivineVanni, Tazioinfo:eu-repo/semantics/openAccess2024-01-19T14:26:43Zoai:seer.ufrgs.br:article/52764Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2024-01-19T14:26:43Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.none.fl_str_mv |
Cervical cancer screening: Barriers to access and potential solutions for Nigeria |
title |
Cervical cancer screening: Barriers to access and potential solutions for Nigeria |
spellingShingle |
Cervical cancer screening: Barriers to access and potential solutions for Nigeria Akwaowo, Christie Divine cervical cancer cancer screening demand -developing countries access Oncology |
title_short |
Cervical cancer screening: Barriers to access and potential solutions for Nigeria |
title_full |
Cervical cancer screening: Barriers to access and potential solutions for Nigeria |
title_fullStr |
Cervical cancer screening: Barriers to access and potential solutions for Nigeria |
title_full_unstemmed |
Cervical cancer screening: Barriers to access and potential solutions for Nigeria |
title_sort |
Cervical cancer screening: Barriers to access and potential solutions for Nigeria |
author |
Akwaowo, Christie Divine |
author_facet |
Akwaowo, Christie Divine Vanni, Tazio |
author_role |
author |
author2 |
Vanni, Tazio |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Akwaowo, Christie Divine Vanni, Tazio |
dc.subject.por.fl_str_mv |
cervical cancer cancer screening demand -developing countries access Oncology |
topic |
cervical cancer cancer screening demand -developing countries access Oncology |
description |
In developed countries, giant strides have been made in reducing mortality due to cervical cancer. The success recorded has been largely attributed to effective screening programmes. In contrast, the burden and mortality due to this disease is rising in developing countries. Access to screening services remains a major challenge for the majority of the population at risk. This paper reviews the current demand-side barriers to cervical cancer screening inNigeriaand identifies potential solutions. Using academic databases and grey literature, a review was carried out to identify current screening modalities, barriers to access, and potential solutions. The current innovative method for control is early detection and treatment using “See and Treat” which involves visual inspection of the cervix with acetic acid (VIA) and cryotherapy. Lack of awareness, cost, and availability were identified as major barriers to access. Potential solutions feasible in the Nigerian context were categorized as financial and non-financial. The potential financial interventions include voucher schemes, conditional cash transfers, health equity, community loan funds, and prepayment mechanisms. Potential non-financial interventions that would be useful include raising awareness via health education and counseling, community participation, community based interventions, and pre-payment mechanisms. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-03-19 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article Avaliados por Pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/52764 |
url |
https://seer.ufrgs.br/index.php/hcpa/article/view/52764 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/52764/33574 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
dc.source.none.fl_str_mv |
Clinical & Biomedical Research; Vol. 35 No. 1 (2015): Clinical and Biomedical Research Clinical and Biomedical Research; v. 35 n. 1 (2015): Clinical and Biomedical Research 2357-9730 reponame:Clinical and Biomedical Research instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Clinical and Biomedical Research |
collection |
Clinical and Biomedical Research |
repository.name.fl_str_mv |
Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
||cbr@hcpa.edu.br |
_version_ |
1799767053719044096 |